Figure 2
From: Liver × receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism
Expression of predicted E2F target genes responsive to liver × receptor (LXR) ligand treatment was validated by quantitative polymerase chain reaction (qPCR). (A-D) Expression of fifteen ligand-responsive E2F target genes in control and LXR ligand-treated cells were validated by qPCR in all four cell lines. Significance was determined by Student's t-test (P < 0.05), and the error bars represent standard error of means from three replicate experiments.